The University of Chicago Header Logo

Connection

Hedy Kindler to Benzenesulfonates

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Benzenesulfonates.
Hedy Kindler
Connection Strength
0.186
Benzenesulfonates
  1. A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307. J Thorac Oncol. 2010 Oct; 5(10):1655-61.
    View in: PubMed
    Score: 0.093
  2. Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Feb; 30(1):382-6.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.